PHARIS BIOTEC GMBH
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 30, 2016 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 74 Total Citation Count
- Mar 27, 1997 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0024,585 Composition for the therapy of diabetes mellitus and adiposityAbandonedApr 11, 11Jan 23, 14[C07K]
2009/0240,031 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragmentsAbandonedJul 27, 07Sep 24, 09[C07K]
2008/0242,609 Composition for the therapy of diabetes mellitus and adiposityAbandonedOct 15, 07Oct 02, 08[A61K, A61P, C07K]
2006/0122,371 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of sameAbandonedMar 21, 05Jun 08, 06[A61K, C07K]
2005/0130,891 Composition for the therapy of diabetes mellitus and adiposityAbandonedMay 13, 04Jun 16, 05[A61K]
2003/0171,536 PROCESS FOR PREPARING CARDIODILATIN FRAGMENTS; HIGHLY PURIFIED CARDIODILATIN FRAGMENTS AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF SAMEAbandonedFeb 23, 98Sep 11, 03[A61K, C07K]
2003/0158,387 Processed human chemokines PHC-1 and PHC-2AbandonedJul 24, 02Aug 21, 03[C07H, A61K, C12P, C12N, C07K]
6326163 Method for the direct diagnostic detection of genetically caused pathogenic point mutationsExpiredApr 06, 99Dec 04, 01[C12Q]
6030790 Antibodies that bind peptides from the hPTH sequence (1-37)ExpiredMar 27, 97Feb 29, 00[G01N, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.